Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sutro Biopharma (STRO) Other Non-Current Assets (2016 - 2025)

Sutro Biopharma (STRO) has disclosed Other Non-Current Assets for 10 consecutive years, with $900000.0 as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets changed 0.0% to $900000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $900000.0 through Dec 2025, changed 0.0% year-over-year, with the annual reading at $900000.0 for FY2025, 0.0% changed from the prior year.
  • Other Non-Current Assets hit $900000.0 in Q4 2025 for Sutro Biopharma, up from $858000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $900000.0 in Q4 2023 to a low of $85000.0 in Q1 2025.
  • Historically, Other Non-Current Assets has averaged $831894.7 across 5 years, with a median of $872000.0 in 2021.
  • Biggest five-year swings in Other Non-Current Assets: soared 5713.33% in 2021 and later plummeted 90.08% in 2025.
  • Year by year, Other Non-Current Assets stood at $872000.0 in 2021, then changed by 0.0% to $872000.0 in 2022, then grew by 3.21% to $900000.0 in 2023, then changed by 0.0% to $900000.0 in 2024, then changed by 0.0% to $900000.0 in 2025.
  • Business Quant data shows Other Non-Current Assets for STRO at $900000.0 in Q4 2025, $858000.0 in Q2 2025, and $85000.0 in Q1 2025.